Insider Brief
- CueZen secured $5 million in funding led by Point72 Ventures to scale customer acquisition, enhance its AI-powered health personalization platform, and forge new enterprise partnerships.
- The platform addresses digital health engagement challenges by integrating sensor data with evidence-based programs, improving user retention, and creating new revenue opportunities for health enterprises.
- Founded in 2021, CueZen supports organizations like Titan, NHS, and Singapore’s health initiatives, personalizing wellness, metabolic, cardiovascular, and sleep health programs for millions.
PRESS RELEASE — CueZen, an AI-based personalization engine for health, has announced a $5 million in funding led by Point72 Ventures, with participation from Pack VC, Fortson VC, and Nextinfinity. The investment will accelerate customer acquisition and expand CueZen’s platform capabilities for health enterprises to personalize their digital offerings.
Health sector enterprises face persistent challenges in driving meaningful user engagement, hindered by fragmented app data, a lack of clinically validated health programs, and rigid integration between sensors and digital solutions — ultimately leading to low user retention and missed revenue opportunities. CueZen’s purpose-built AI platform directly addresses these challenges by seamlessly orchestrating sensor technologies with evidence-based health programs. By bridging the gap between data collection and actionable interventions, CueZen empowers companies to boost user engagement, improve retention, and unlock new revenue opportunities. Its platform enhances customer lifetime value through personalized health programs tailored to areas such as general wellness, women’s health, metabolic health, cardiovascular care, and sleep disorders.
“At CueZen, we are committed to making health and wellness truly personal — because that’s where real change begins, “ said Ankur Teredesai, CEO and Co-Founder of CueZen. “This investment is not just fuel for growth — it’s a signal of market readiness for AI that turns everyday lifestyle and clinical data into actions that help millions improve their health. We will leverage this capital to expand our enterprise partnerships, deepen platform capabilities, and unlock measurable ROI — all while delivering personalization in health at unprecedented scale.”
“We believe CueZen is addressing a significant gap in the digital health ecosystem,” said Tara Stokes, Partner at Point72 Ventures. “Their platform has the potential to fundamentally change how health data is leveraged across the industry. We’re impressed by the early impact they’ve demonstrated and are excited to support their vision of creating better health outcomes while enabling new revenue streams for technology companies and providers in this space.”
The funding will be used to grow sales and AI teams, accelerate product development, and form strategic partnerships with leading health technology companies.
About CueZen
Founded in 2021, CueZen is a global health technology company. CueZen’s AI platform helps Health OEMs create value from personalized health engagement. Organizations like Titan, NHS, Microport use CueZen to increase enrolment, engagement and adherence to offer personalized programs, outcomes, journeys, coaches and nudges to their customers. Singapore uses CueZen to evaluate and deliver personalized interventions daily to over 3 million residents for better disease prevention.
For more information, please visit www.cuezen.com
Contacts
Media Contact: Ananth S Kumar
Email: [email protected]
CueZen, Inc.
